Cover Image

Uncovering cancer vulnerabilities by machine learning prediction of synthetic lethality

Background: Synthetic lethality describes a genetic interaction between two perturbations, leading to cell death, whereas neither event alone has a significant effect on cell viability. This concept can be exploited to specifically target tumor cells. CRISPR viability screens have been widely employ...

Full description

Saved in:
Bibliographic Details
Main Authors: Benfatto, Salvatore (Author) , Serçin, Özdemirhan (Author) , Dejure, Francesca Romana (Author) , Abdollahi, Amir (Author) , Zenke, Frank T. (Author) , Mardin, Balca (Author)
Format: Article (Journal)
Language:English
Published: 28 August 2021
In: Molecular cancer
Year: 2021, Volume: 20, Pages: 1-22
ISSN:1476-4598
DOI:10.1186/s12943-021-01405-8
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s12943-021-01405-8
Verlag, lizenzpflichtig, Volltext: https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=DynamicDOIArticle&SrcApp=WOS&KeyAID=10.1186%2Fs12943-021-01405-8&DestApp=DOI&SrcAppSID=E3GfDbCMTZ6UPOXkjTs&SrcJTitle=MOLECULAR+CANCER&DestDOIRegistrantName=Springer+%28Biomed+Central+Ltd.%29
Get full text
Author Notes:Salvatore Benfatto, Özdemirhan Serçin, Francesca R. Dejure, Amir Abdollahi, Frank T. Zenke and Balca R. Mardin
Description
Summary:Background: Synthetic lethality describes a genetic interaction between two perturbations, leading to cell death, whereas neither event alone has a significant effect on cell viability. This concept can be exploited to specifically target tumor cells. CRISPR viability screens have been widely employed to identify cancer vulnerabilities. However, an approach to systematically infer genetic interactions from viability screens is missing. Methods: Here we describe PAn-canceR Inferred Synthetic lethalities (PARIS), a machine learning approach to identify cancer vulnerabilities. PARIS predicts synthetic lethal (SL) interactions by combining CRISPR viability screens with genomics and transcriptomics data across hundreds of cancer cell lines profiled within the Cancer Dependency Map. Results: Using PARIS, we predicted 15 high confidence SL interactions within 549 DNA damage repair (DDR) genes. We show experimental validation of an SL interaction between the tumor suppressor CDKN2A, thymidine phosphorylase (TYMP) and the thymidylate synthase (TYMS), which may allow stratifying patients for treatment with TYMS inhibitors. Using genome-wide mapping of SL interactions for DDR genes, we unraveled a dependency between the aldehyde dehydrogenase ALDH2 and the BRCA-interacting protein BRIP1. Our results suggest BRIP1 as a potential therapeutic target in similar to 30% of all tumors, which express low levels of ALDH2. Conclusions: PARIS is an unbiased, scalable and easy to adapt platform to identify SL interactions that should aid in improving cancer therapy with increased availability of cancer genomics data.
Item Description:Gesehen am 13.10.2021
Physical Description:Online Resource
ISSN:1476-4598
DOI:10.1186/s12943-021-01405-8

Similar Items